ASCO--for those running out of options, a new vinca alkaloid

[Lani]

(same drug class as vincristine) combined with herceptin active in Phase II trials

http://clinicaloptions.com/Oncology/Conference%20Coverage/Clin%20Onc%20June%202007/Tracks/Breast%20Cancer/Capsules/1043.aspx

[Joy]

Not that it isn't good news, but this study was first line treatment for MBC. Could it be active in the heavily pretreated population I wonder?